Thomas Malley
CIK 1403322 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.03M
Companies
7
Total Filings
70
Lifetime Open-Market Net
-$1.87M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | Director | 149,557 | $9.05 | $1.35M | $975.0K | 14 | 2026-06-04 |
| KNSA | Director | 87,312 | $51.89 | $4.53M | -$5.86M | 11 | 2026-06-02 |
| BeOne Medicines Ltd. (BGNE) Delisted | Director | 46,696 | $184.71 | $8.63M | $960.0K | 8 | 2023-06-20 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 204,981 | — | — | $1.89M | 16 | 2017-07-05 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Director | 0 | — | — | $0 | 6 | 2015-06-23 |
| PBYI | Director | 156,551 | $7.33 | $1.15M | $160.0K | 4 | 2014-12-16 |
| Cougar Biotechnology, Inc. (CGRB) Delisted | Director | 0 | — | — | $0 | 2 | 2009-07-07 |
Recent Filings · Page 5 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-05 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +1,356 | $0 | EDGAR |
| 2015-12-17 | KURA | Buy (P) | +50,000 | $400.0K | EDGAR |
| 2015-10-14 | — | Grant (A) | — | $0 | |
| 2015-10-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +1,560 | $0 | EDGAR |
| 2015-07-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +458 | $13.2K | EDGAR |
| 2015-06-23 | SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | Disp (D) | −46,901 | $0 | EDGAR |
| 2015-06-08 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-09 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +5,000 | $142.5K | EDGAR |
| 2015-04-02 | Tempest Therapeutics, Inc. (OVAS) Delisted | Grant (A) | +381 | $13.2K | EDGAR |
| 2015-01-15 | Tempest Therapeutics, Inc. (OVAS) Delisted | Buy (P) | +35,000 | $1.75M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.